The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis

Kidney International

Volumn 83, Issue 3, 2013, Pages 463-470

  Nasr, Samih H ^a   Said, Samar M ^a   Valeri, Anthony M ^b   Sethi, Sanjeev ^a   Fidler, Mary E ^a   Cornell, Lynn D ^a   Gertz, Morie A ^a   Dispenzieri, Angela ^a   Buadi, Francis K ^a   Vrana, Julie A ^a   Theis, Jason D ^a   Dogan, Ahmet ^a   Leung, Nelson ^a  

^a MAYO CLINIC   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

cancer; immunology and pathology; multiple myeloma; proteinuria; renal biopsy

Indexed keywords

CONGO RED; PARAPROTEIN;

ADULT; BONE MARROW BIOPSY; CAUCASIAN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEART; HEAVY CHAIN DISEASE; HEMATOLOGICAL PARAMETERS; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; LASER MICRODISSECTION; LIGHT CHAIN; MALE; MASS SPECTROMETRY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL;

EID: 84874696372     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.414     Document Type: Article

References (34)

1. Kyle RA, Linos A, Beard CM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992; 79: 1817-1822
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59
3. Obici L, Perfetti V, Palladini G et al. Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005; 1753: 11-22
4. Solomon A, Frangione B, Franklin EC. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982; 70: 453-460
5. Glenner GG. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med 1980; 302: 1283-1292
6. Olsen KE, Sletten K, Westermark P. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun 1998; 251: 642-647
7. Klimtchuk ES, Gursky O, Patel RS et al. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry 2010; 49: 9848-9857
8. Engvig JP, Olsen KE, Gislefoss RE et al. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 1998; 48: 92-98
9. Kaplan B, Martin BM, Boykov O et al. Co-deposition of amyloidogenic immunoglobulin light and heavy chains in localized pulmonary amyloidosis. Virchows Arch 2005; 447: 756-761
10. Nasr SH, Colvin R, Markowitz G. IgG1[lambda] light and heavy chain renal amyloidosis. Kidney Int 2006; 70: 7
11. Sethi S, Theis JD, Leung N et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol 2010; 5: 2180-2187
12. Eulitz M, Weiss DT, Solomon A. Immunoglobulin heavy chain-associated amyloidosis. Proc Natl Acad Sci USA 1990; 87: 6542-6546
13. Solomon A, Weiss DT, Murphy C. Primary amyloidosis associated with a novel heavy-chain fragment (AH amyloidosis). Am J Hematol 1994; 45: 171-176
14. Tan SY, Murdoch IE, Sullivan TJ et al. Primary localized orbital amyloidosis composed of the immunoglobulin gamma heavy chain CH3 domain. Clin Sci 1994; 87: 487-491
15. Nasr S, Lobritto S, Lauring B et al. A rare complication of monoclonal gammopathy. Am J Kidney Dis 2002; 40: 867-871
16. Mai HL, Sheikh-Hamad D, Herrera GA et al. Immunoglobulin heavy chain can be amyloidogenic: Morphologic characterization including immunoelectron microscopy. Am J Surg Pathol 2003; 27: 541-545
17. Copeland JN, Kouides PA, Grieff M et al. Metachronous development of nonamyloidogenic [lambda] light chain deposition disease and IgG heavy chain amyloidosis in the same patient. Am J Surg Pathol 2003; 27: 1477-1482
18. Yazaki M, Fushimi T, Tokuda T et al. A patient with severe renal amyloidosis associated with an immunoglobulin gamma-heavy chain fragment. Am J Kidney Dis 2004; 43: E23-e28
19. Gono T, Yazaki M, Fushimi T et al. AH amyloidosis associated with lymphoplasmacytic lymphoma secreting a monoclonal gamma heavy chain carrying an unusual truncated D segment. Am J Kidney Dis 2006; 47: 908-914
20. Miyazaki D, Yazaki M, Gono T et al. AH amyloidosis associated with an immunoglobulin heavy chain variable region (VH1) fragment: A case report. Amyloid 2008; 15: 125-128
21. Pradhan MA, Henderson RA, Patel D et al. Heavy-chain amyloidosis in TGFBI-negative and gelsolin-negative atypical lattice corneal dystrophy. Cornea 2011; 30: 1163-1166
22. D'Agati VD, Jennette JC, Silva FG. Atlas of Nontumor Pathology: Non-Neoplastic Kidney Diseases. American Registry of Pathology-Armed Forces Institute of Pathology: Washington, DC, 2005; 189-237
23. Kebbel A, Ro?cken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 2006; 30: 673-683
24. Picken MM, Herrera GA. The burden of 'sticky' amyloid: Typing challenges. Arch Pathol Lab Med 2007; 131: 850-851
25. Satoskar AA, Burdge K, Cowden DJ et al. Typing of amyloidosis in renal biopsies: Diagnostic pitfalls. Arch Pathol Lab Med 2007; 131: 917-22.24
26. Sethi S, Vrana JA, Theis JD et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 2012; 82: 226-234
27. Enqvist S, Sletten K, Westermark P. Fibril protein fragmentation pattern in systemic AL-amyloidosis. J Pathol 2009; 219: 473-480
28. Buxbaum JN. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease. Amyloid 2001; 8: 84-93
29. Nasr SH, Valeri AM, Sethi S et al. Clinicopathologic correlations in multiple myeloma: A case series of 190 patients with kidney biopsies. Am J Kidney Dis 2012; 59: 786-794
30. Vrana JA, Gamez JD, Madden BJ et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009; 114: 4957-4959
31. Sethi S, Gamez JD, Vrana JA et al. Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway. Kidney Int 2009; 75: 952-960
32. Gertz MA, Comenzo R, Falk RH et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005; 79: 319-328
33. Leung N, Dispenzieri A, Lacy MQ et al. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation. Clin J Am Soc Nephrol 2007; 2: 440-444
34. Kumar SK, Dispenzieri A, Lacy MQ et al. Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis. Am J Hematol 2011; 86: 251-255